中文 EN

info@singleronbio.com
+49 221 16824777

Breakthrough| Singleron show you around ASCO summit

发布时间:2019-03-11 21:17:36阅读次数:459
分享到:

The ASCO Breakthrough Summit successfully concluded on 13 October 2019 in Bangkok. This summit is the world’s first global breakthrough summit for oncologists, who brought the very latest discoveries in oncological field focusing on cancer screening and prevention, cancer diagnosis, cancer treatment and patient care. It covers the cutting-edge technologies such as artificial intelligence, single cell sequencing, surgical robot, etc. The summit inspired innovation and will transform the future of cancer care.

 

Summit Summary 

 

2-2.png


Singleron Poster

The Poster of cooperative study by Nanjing Medical University Affiliated Cancer Hospital and Singleron was awarded the ASCO Abstract Award. 

2-3.png

A transcriptomic landscape of cancer and TME in early-stage lung adenocarcinoma by single-cell sequencing

 

In this study, tumor tissue and blood samples of 28 early-stage NSCLC patients were collected and single-cell transcriptome sequencing and whole exome sequencing were performed. This study provided a detailed cell atlas of early-stage lung adenocarcinoma and identified gene expression patterns of tumor and TME cell sub-clusters. By comparing TME cells among patients with different mutation status, we identified changes in various tumor-infiltrating T cell subtypes and myeloid cells. Single-cell analyses offer valuable knowledge of immune changes for each patient subgroup, providing a useful tool for the rational design of immune therapies. Further study on an early-stage NSCLC patient with lymphatic metastasis identified a serious of marker genes and pathways, which might provide special value for clinical diagnosis for NSCLC. 

QQ截图20200311212236.png
        Dr. Siwei Wang, Jiangsu Cancer Hospital                                                         Yiqi Zhou, Singleron 

 

During the ASCO summit, many researchers came to the Poster of Singleron to discuss with us on the potential applications of single-cell sequencing technology, especially the applications in cancer precision medicine.

Copyright © 2019 Singleron Biotechnologies.   流量统计 苏ICP备19004238号-1